HomeCompareCEBTF vs MRK

CEBTF vs MRK: Dividend Comparison 2026

CEBTF yields 18181.82% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CEBTF wins by $20382968138483965952.00M in total portfolio value
10 years
CEBTF
CEBTF
● Live price
18181.82%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20382968138483965952.00M
Annual income
$20,164,798,479,641,134,000,000,000.00
Full CEBTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CEBTF vs MRK

📍 CEBTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCEBTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CEBTF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CEBTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CEBTF
Annual income on $10K today (after 15% tax)
$1,545,454.55/yr
After 10yr DRIP, annual income (after tax)
$17,140,078,707,694,964,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CEBTF beats the other by $17,140,078,707,694,964,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CEBTF + MRK for your $10,000?

CEBTF: 50%MRK: 50%
100% MRK50/50100% CEBTF
Portfolio after 10yr
$10191484069241982976.00M
Annual income
$10,082,399,239,820,567,000,000,000.00/yr
Blended yield
98.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CEBTF
No analyst data
Altman Z
0.9
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CEBTF buys
0
MRK buys
0
No recent congressional trades found for CEBTF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCEBTFMRK
Forward yield18181.82%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20382968138483965952.00M$56.8K
Annual income after 10y$20,164,798,479,641,134,000,000,000.00$9,798.13
Total dividends collected$20368560651224936448.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CEBTF vs MRK ($10,000, DRIP)

YearCEBTF PortfolioCEBTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,828,882$1,818,181.82$11,206$366.19+$1.82MCEBTF
2$312,726,966$310,770,062.56$12,650$502.35+$312.71MCEBTF
3$49,997,862,140$49,663,244,286.24$14,407$694.19+$49997.85MCEBTF
4$7,474,070,205,933$7,420,572,493,443.65$16,585$967.82+$7474070.19MCEBTF
5$1,044,712,232,322,833$1,036,714,977,202,484.10$19,342$1,363.89+$1044712232.30MCEBTF
6$136,547,911,758,351,100$135,430,069,669,765,680.00$22,913$1,947.19+$136547911758.33MCEBTF
7$16,689,313,388,956,088,000$16,543,207,123,374,653,000.00$27,662$2,823.89+$16689313388956.06MCEBTF
8$1,907,542,220,817,720,100,000$1,889,684,655,491,537,200,000.00$34,159$4,173.35+$1907542220817720.25MCEBTF
9$203,896,877,423,206,970,000,000$201,855,807,246,932,000,000,000.00$43,337$6,308.80+$203896877423206976.00MCEBTF
10$20,382,968,138,483,967,000,000,000$20,164,798,479,641,134,000,000,000.00$56,776$9,798.13+$20382968138483965952.00MCEBTF

CEBTF vs MRK: Complete Analysis 2026

CEBTFStock

Citychamp Watch & Jewellery Group Limited, an investment holding company, manufactures, sells, and distributes watches and timepieces in Hong Kong, the People's Republic of China, Switzerland, the United Kingdom, Liechtenstein, and internationally. The company operates through Manufacturing and Distribution of Watches and Timepieces, Property Investments, and Banking and Financial Businesses segments. It offers watches and timepieces under the Rossini, Corum, Eterna, Dreyfuss & Co, J&T Windmills, Ernest Borel, and Rotary brands. The company is also involved in the property investment activities; distribution of glasses; and issuance of bonds. In addition, it operates a bank in Liechtenstein that offer financial services, including accepting client deposits and granting loans; and portfolio management, investment advice, transaction banking, and investment fund services for entrepreneurial families and individuals. Further, the company provides investment counselling services; acts as technical administrator of fund units; dealing and advising in securities; and watch maintenance and repairment, and technical advisory services, as well as acts as an alternative investment fund manager. The company was formerly known as China Haidian Holdings Limited and changed its name to Citychamp Watch & Jewellery Group Limited in May 2014. Citychamp Watch & Jewellery Group Limited is based in Kowloon, Hong Kong.

Full CEBTF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CEBTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CEBTF vs SCHDCEBTF vs JEPICEBTF vs OCEBTF vs KOCEBTF vs MAINCEBTF vs JNJCEBTF vs ABBVCEBTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.